Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing | Breast Cancer | JAMA | JAMA Network

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing | Breast Cancer | JAMA | JAMA Network

Direct-to-Consumer Genetic TestingThe Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing

Jennifer Gill, MS¹; Adam J. Obley, MD²; Vinay Prasad, MD, MPH^1,3

Author Affiliations Article Information

JAMA. Published online May 18, 2018. doi:10.1001/jama.2018.5330